Critical Care Anxiety and Long-Term Outcomes Management

Phase 2TerminatedNCT02421861

University of Washington10 enrolled

Overview

The aims of this study are to (1) test the benefits of a non-pharmacologic anxiety management approach with patients who are critically ill and/or traumatically injured during intensive care hospitalization and (2) test whether this approach reduces anxiety and improves engagement in rehabilitation therapies, shortens duration of hospitalization, and improves psychological and quality of life outcomes.

Study Type

INTERVENTIONAL

Allocation

RANDOMIZED

Purpose

TREATMENT

Masking

SINGLE

Enrollment

Conditions

Anxiety

Interventions

Anxiety Management in the ICUBEHAVIORAL

The AM intervention is based on a Cognitive-Behavioral Therapy (CBT) approach, empirically supported in other settings, though we do not know whether this approach will be effective for ICU patients. It will offer all participants core aspects of CBT including: (1) establish rapport/therapeutic alliance; (2) anxiety psychoeducation; (3) normalization of difficulties; (4) establishment of a sense of hope; (5) reflective listening; (6) supportive statements; (7) exposure to anxious thoughts/feelings; (8) directive statements; and (9) provision of coping strategies. It will consist of modules that include the aforementioned core aspects and "optional" modules based on each participant's anxiety experience and preference.

Usual Care (UC)OTHER

The UC group will receive usual care as per the Harborview Medical Center usual care standard. Because this is an effectiveness trial, treatment decisions for UC participants will be left to the discretion of the primary provider and/or primary medical team and may or may not include: (1) referral to rehab psychology C\&L service; (2) referral to psychiatry C\&L service; or (3) pharmacologic management.

Eligibility

Sex: ALLMin age: 18 Years

Medical Language ↔ Plain English

Inclusion Criteria: * 18 years or older * Ability to read, write, and speak English * Alert (Best RASS ICU sedation score ≥-2) * Current CAM-ICU test negative * Expected ICU stay ≥48 hours * Anxiety Visual Analog Scale (VAS-A) score ≥30 * Prescribed rehabilitation therapy at eligibility Exclusion Criteria: * Inability to communicate (verbally, or via hand writing/gestures) * Greater than 90% probability of mortality in hospital * Anticipated discharge to hospice or transition to end-of-life care * Pre-existing cognitive impairment (e.g., dementia, pervasive developmental disorder)

Outcomes

Primary Outcomes

Anxiety (Visual Analog Scale for Anxiety (VAS-A)

Anxiety at discharge and change in anxiety from baseline to discharge as measured by the Visual Analog Scale for Anxiety (VAS-A)

Time frame: Participants will be followed for the duration of hospitalization, an expected average of 13 days and not more than 45 days

Secondary Outcomes

Engagement in rehabilitation therapies (As measured by a 2-item engagement questionnaire)

Time frame: As measured by a 2-item engagement questionnaire (developed specifically for this study) at the time of hospital discharge (i.e., based on an expected average duration of hospitalization of 13 days and not more than 45 days)

Length of ICU and Hospital Stay

Time frame: Measured in days (an expected average ICU stay=5 days and average Hospital stay=13 days and not more than 45 days)

Long-Term Anxiety and Depressive Symptoms (as measured by the Hospital Anxiety and Depression Scale (HADS)

Time frame: 3 months after enrollment as measured by the Hospital Anxiety and Depression Scale (HADS)

Long-Term Posttraumatic Stress Symptoms (as measured by the PCL-5)

Time frame: 3 months after enrollment as measured by the PCL-5

Health-Related Quality of Life (as measured by the EQ-5D-5L and SF-36)

Time frame: 3 months after enrollment

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.